Taurus Vascular Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
5
Taurus Vascular General Information
Description
Developer of a medical device company designed to transform the standard of care for patients with aortic aneurysms. The company is developing a novel medical device technology to eliminate the negative effects of endoleaks and facilitate accelerated aneurysm sac shrinkage after endovascular aortic aneurysm repair (EVAR), enabling the healthcare industry to improve patient outcomes and better long-term patient outcomes.
Contact Information
Website
www.taurusvascular.comCorporate Office
- 2450 Holcombe Boulevard
- Suite CDI
- Houston, TX 77021
- United States
Corporate Office
- 2450 Holcombe Boulevard
- Suite CDI
- Houston, TX 77021
- United States
Taurus Vascular Timeline
Taurus Vascular Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Accelerator/Incubator | 29-May-2024 | Completed | Pre-Clinical Trials | |||
| 5. Accelerator/Incubator | 22-May-2024 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 01-Mar-2024 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | 26-Jul-2023 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | 01-May-2023 | $300K | Completed | Pre-Clinical Trials | ||
| 1. Accelerator/Incubator | 01-Jan-2022 | $300K | $300K | Completed | Pre-Clinical Trials |
Taurus Vascular Patents
Taurus Vascular Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026024887-A1 | Methods and systems for robotic transcaval treatment of aneurysms | Pending | 24-Jul-2024 | ||
| US-12310837-B1 | Methods and systems for transcaval treatment of aneurysms | Active | 24-Jul-2024 | ||
| US-20250262044-A1 | Methods and systems for transcaval treatment of aneurysms | Pending | 24-Jul-2024 | ||
| WO-2025160095-A1 | Methods and systems for transcaval treatment of aneurysms | Pending | 22-Jan-2024 | ||
| US-12318563-B1 | Methods and systems for transcaval treatment of aneurysms | Active | 02-Feb-2021 | A61M27/002 |
Taurus Vascular Signals
Taurus Vascular Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MedTech Innovator | Accelerator/Incubator | |||
| Texas A&M New Ventures Competition | University | Minority | ||
| MassChallenge | Accelerator/Incubator | |||
| OwlSpark | Accelerator/Incubator | Minority | ||
| Texas Medical Center | Venture Capital | Minority |
Taurus Vascular FAQs
-
When was Taurus Vascular founded?
Taurus Vascular was founded in 2022.
-
Where is Taurus Vascular headquartered?
Taurus Vascular is headquartered in Houston, TX.
-
What is the size of Taurus Vascular?
Taurus Vascular has 3 total employees.
-
What industry is Taurus Vascular in?
Taurus Vascular’s primary industry is Surgical Devices.
-
Is Taurus Vascular a private or public company?
Taurus Vascular is a Private company.
-
What is Taurus Vascular’s current revenue?
The current revenue for Taurus Vascular is .
-
How much funding has Taurus Vascular raised over time?
Taurus Vascular has raised $1.83M.
-
Who are Taurus Vascular’s investors?
MedTech Innovator, Texas A&M New Ventures Competition, MassChallenge, OwlSpark, and Texas Medical Center have invested in Taurus Vascular.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process